2021
DOI: 10.3390/cancers13153869
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer

Abstract: Keratins are the main identification markers of circulating tumor cells (CTCs); however, whether their deregulation is associated with the metastatic process is largely unknown. Previously we have shown by in silico analysis that keratin 16 (KRT16) mRNA upregulation might be associated with more aggressive cancer. Therefore, in this study, we investigated the biological role and the clinical relevance of K16 in metastatic breast cancer. By performing RT-qPCR, western blot, and immunocytochemistry, we investiga… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 39 publications
0
9
0
Order By: Relevance
“…Keratins have been revealed to play a vital role in the tumorigenesis of numerous cancer types [38][39][40]. In HNSC, highly keratinized squamous cell carcinoma exhibits an improved response to treatment and prognosis compared with weakly keratinized cancer [41].…”
Section: Discussionmentioning
confidence: 99%
“…Keratins have been revealed to play a vital role in the tumorigenesis of numerous cancer types [38][39][40]. In HNSC, highly keratinized squamous cell carcinoma exhibits an improved response to treatment and prognosis compared with weakly keratinized cancer [41].…”
Section: Discussionmentioning
confidence: 99%
“…KRT 6A, 16 and 17 were upregulated only in MFUM-BrTNBC-1 compared to MCF-7. Upregulated KRT 6A, 16 and 17 have been associated with EMT in cancer cells [ 60 , 61 , 62 ].…”
Section: Resultsmentioning
confidence: 99%
“…Many keratin genes have been found to affect the occurrence and treatment of breast cancer. Overexpression of KRT16 enhances cell motility and promotes breast cancer metastasis (Elazezy et al, 2021). KRT19 regulates cell proliferation and can predict the effect of CDK inhibitor treatment (Sharma et al, 2019).…”
Section: Frontiers In Geneticsmentioning
confidence: 99%